Skip to main content
Premium Trial:

Request an Annual Quote

Beckman's Acquisition of Olympus Dx Business Clears FTC

NEW YORK (GenomeWeb News) – Beckman Coulter today said that its pending $780 million acquisition of the diagnostics business of Olympus has cleared US antitrust review by the Federal Trade Commission.

The firm said that it expects to close the deal in the third quarter of 2009, subject to certain additional conditions including approval from governments outside of the US.

Beckman announced the deal, which will provide it with an expanded clinical chemistry offering with particular strength in the larger hospital laboratories, at the end of February.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.